# A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

> **NCT06151223** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 5000 (estimated)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- PDAC
- PDAC - Pancreatic Ductal Adenocarcinoma

## Interventions

- **OTHER:** Bio-specimen Collection: Blood
- **OTHER:** Bio-specimen Collection: Pancreatic Juice
- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT06151223
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-13
- **Primary completion:** 2031-07-31
- **Final completion:** 2031-07-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06151223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06151223, "A Prospective Registry for Patients at High-Risk for Pancreatic Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06151223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*